WiseApp for Sexually Transmitted Diseases, Viral

Phase-Based Progress Estimates
Columbia University Irving Medical Center, New York, NY
Sexually Transmitted Diseases, Viral+6 More
WiseApp - Behavioral
All Sexes
What conditions do you have?

Study Summary

This study aims to conduct a 12-month randomized controlled trial to adapt the mobile app, WiseApp, and a smart pill dispenser for Spanish-speaking people living with HIV (PLWH) in the New York City (NYC) area and La Romana, Dominican Republic (DR). The study will assess the efficacy and sustainability of WiseApp as well as identify barriers with its widespread use among Spanish speakers. With disproportionately high rates of HIV in the New York City area and the Dominican Republic, this project seeks to identify distinct contextual factors related to Spanish speaking people living with HIV and increase the likelihood of engagement with technology and improvements in clinical outcomes.

Eligible Conditions

  • Sexually Transmitted Diseases, Viral
  • HIV Infections
  • Acquired Immunodeficiency Syndrome

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Sexually Transmitted Diseases, Viral

Study Objectives

1 Primary · 6 Secondary · Reporting Duration: Baseline, 3 month follow up, 6 month follow up, and 12 month follow up

Month 12
Change In Participant's Self-reported Health-related Quality of Life Score
Change in Engagement with Health Care Provider Score
Change in HIV Stigma Mechanism Measure Score
Change in Symptom Burden Score
Change in Viral Load
Change in self-reported ART adherence
Month 6
Change in cluster of differentiation 4 (CD4) Count

Trial Safety

Safety Progress

1 of 3

Other trials for Sexually Transmitted Diseases, Viral

Trial Design

2 Treatment Groups

1 of 2
1 of 2
Active Control
Experimental Treatment

248 Total Participants · 2 Treatment Groups

Primary Treatment: WiseApp · No Placebo Group · N/A

Experimental Group · 1 Intervention: WiseApp · Intervention Types: Behavioral
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 3 month follow up, 6 month follow up, and 12 month follow up
Closest Location: Columbia University Irving Medical Center · New York, NY
Photo of New York 1Photo of New York 2Photo of New York 3
2002First Recorded Clinical Trial
1 TrialsResearching Sexually Transmitted Diseases, Viral
73 CompletedClinical Trials

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,266 Previous Clinical Trials
1,573,568 Total Patients Enrolled
Clínica de Familia La Romana, Dominican RepublicUNKNOWN
Rebecca Schnall, PhD, MPHPrincipal InvestigatorColumbia University
1 Previous Clinical Trials
80 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are aged at least 18 years.\n
You own a smartphone.\n
You are able to give informed consent for study participation and access to medical records.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.